| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |